Suppr超能文献

外周血甲基化水平与肺癌的发生发展相关

[Peripheral blood methylation level is associated with the occurrence and progression of lung cancer].

作者信息

Zang Z, Qiao R, Zhu Q, Zhou X, Gu W, Han B, Yang R

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China.

Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2023 Mar 20;43(3):349-359. doi: 10.12122/j.issn.1673-4254.2023.03.03.

Abstract

OBJECTIVE

To explore the association of gene methylation levels in peripheral blood with lung cancer.

METHODS

The methylation levels of 4 CpG sites in gene were quantitatively detected in 285 patients with lung cancer, 186 age- and sex-matched patients with benign pulmonary nodules and 278 matched healthy control subjects using mass spectrometry (MALDI-TOF-MS). The association of methylation levels with lung cancer was analyzed using logistic regression models adjusted for covariates. The methylation levels in different subgroups of lung cancer patients were compared using Mann-Whitney test.

RESULTS

In subjects over 55 years and in female subjects, the highest quartile (Q4) the lowest quartile (Q1) of KCNMA1_CpG_5 methylation levels were significantly correlated with lung cancer (for subjects over 55 years: OR=2.60, 95% : 1.25-5.41, =0.011; for female subjects: OR=2.09, 95% : 1.03?4.26, =0.042). From Q2 to Q4 of KCNMA1_CpG_5 methylation levels, their correlation with lung cancer became gradually stronger (=0.003 and 0.038, respectively). In male subjects, the OR of Q4 of KCNMA1_CpG_5 methylation levels was 0.35 in patients with lung cancer as compared with patients with benign nodules (95% : 0.16-0.79, =0.012). KCNMA1_CpG_3 methylation level was significantly lower in invasive adenocarcinoma than in noninvasive adenocarcinoma (=0.028), and that of KCNMA1_CpG_1 was significantly higher in patients with larger tumors (T2-4) than in those with smaller tumors (T1) (=0.021).

CONCLUSION

The change of peripheral blood methylation level is correlated with the occurrence and development of lung cancer.

摘要

目的

探讨外周血基因甲基化水平与肺癌的关联。

方法

采用基质辅助激光解吸电离飞行时间质谱法(MALDI-TOF-MS)对285例肺癌患者、186例年龄和性别匹配的良性肺结节患者以及278例匹配的健康对照者进行基因中4个CpG位点甲基化水平的定量检测。使用经协变量调整的逻辑回归模型分析甲基化水平与肺癌的关联。采用Mann-Whitney U检验比较肺癌患者不同亚组中的甲基化水平。

结果

在55岁以上人群和女性受试者中,KCNMA1_CpG_5甲基化水平的最高四分位数(Q4)与最低四分位数(Q1)与肺癌显著相关(55岁以上人群:OR=2.60,95%CI:1.25-5.41,P=0.011;女性受试者:OR=2.09,95%CI:1.03-4.26,P=0.042)。从KCNMA1_CpG_5甲基化水平的Q2到Q4,它们与肺癌的相关性逐渐增强(P分别为0.003和0.038)。在男性受试者中,与良性结节患者相比,肺癌患者中KCNMA1_CpG_5甲基化水平Q4的OR为0.35(95%CI:0.16-0.79,P=0.012)。KCNMA1_CpG_3甲基化水平在浸润性腺癌中显著低于非浸润性腺癌(P=0.028),而KCNMA1_CpG_1在肿瘤较大(T2-4)的患者中显著高于肿瘤较小(T1)的患者(P=0.021)。

结论

外周血甲基化水平的变化与肺癌的发生发展相关。

相似文献

1
[Peripheral blood methylation level is associated with the occurrence and progression of lung cancer].
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Mar 20;43(3):349-359. doi: 10.12122/j.issn.1673-4254.2023.03.03.
3
A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA.
Cancer Med. 2022 Jan;11(1):281-294. doi: 10.1002/cam4.4431. Epub 2021 Dec 2.
4
Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Virchows Arch. 2015 Jun;466(6):675-83. doi: 10.1007/s00428-015-1749-0. Epub 2015 Mar 13.
6
Novel blood-based hypomethylation of SH3BP5 is associated with very early-stage lung adenocarcinoma.
Genes Genomics. 2022 Apr;44(4):445-453. doi: 10.1007/s13258-021-01190-0. Epub 2021 Nov 16.
7
methylation in peripheral blood as a potential marker for the early-stage lung cancer: a case-control study in Chinese population.
Biomarkers. 2022 Feb;27(1):79-85. doi: 10.1080/1354750X.2021.2016970. Epub 2021 Dec 20.
8
DNA methylation and RNA expression profiles in lung adenocarcinomas of never-smokers.
Cancer Genet. 2015 May;208(5):253-60. doi: 10.1016/j.cancergen.2014.12.002. Epub 2014 Dec 31.
10
Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Aging (Albany NY). 2020 Nov 24;12(23):23917-23930. doi: 10.18632/aging.104062.

本文引用的文献

1
Hypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer.
Clin Chim Acta. 2022 Dec 1;537:173-180. doi: 10.1016/j.cca.2022.10.014. Epub 2022 Nov 1.
3
Identification of genes and pathways associated with sex in Non-smoking lung cancer population.
Gene. 2022 Jul 15;831:146566. doi: 10.1016/j.gene.2022.146566. Epub 2022 May 14.
4
methylation in peripheral blood as a potential marker for the early-stage lung cancer: a case-control study in Chinese population.
Biomarkers. 2022 Feb;27(1):79-85. doi: 10.1080/1354750X.2021.2016970. Epub 2021 Dec 20.
5
Novel blood-based hypomethylation of SH3BP5 is associated with very early-stage lung adenocarcinoma.
Genes Genomics. 2022 Apr;44(4):445-453. doi: 10.1007/s13258-021-01190-0. Epub 2021 Nov 16.
6
The Association Between Methylation in Peripheral Blood and Early-Stage Lung Cancer in a Case-Control Study.
Cancer Manag Res. 2021 Oct 15;13:7919-7927. doi: 10.2147/CMAR.S329629. eCollection 2021.
7
Current and Future Development in Lung Cancer Diagnosis.
Int J Mol Sci. 2021 Aug 12;22(16):8661. doi: 10.3390/ijms22168661.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma.
Medicine (Baltimore). 2021 Jan 8;100(1):e24150. doi: 10.1097/MD.0000000000024150.
10
The Association Between RAPSN Methylation in Peripheral Blood and Early Stage Lung Cancer Detected in Case-Control Cohort.
Cancer Manag Res. 2020 Nov 2;12:11063-11075. doi: 10.2147/CMAR.S275321. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验